REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

Click here to see the details because there’s a lot of money at stake.

Andrew Ross Biography and Net Worth

Director of iSpecimen

Andrew L. Ross has been serving as our director since 2012. He has been an entrepreneur and investor for almost 50 years. He developed, financed, owned and managed through controlled entities multiple real estate assets, including apartment units, hotels, a golf course, a condominium project, several office and retail commercial properties. Since 2010, Mr. Ross has focused on angel and early-stage investments primarily in biotech and collaborative consumption businesses. He has invested in and advised multiple early-stage enterprises as a seed, angel or A-round investor. Mr. Ross served as a director on the board of Q-State Holdings, Inc., a subsidiary of Q-State Biosciences, Inc., a precision medicine company, from 2013 to February 2020. He is well-qualified to serve on our Board due to his extensive experience in investment.

How do I contact Andrew L. Ross?: The corporate mailing address for Mr. Ross and other iSpecimen executives is , , . iSpecimen can also be reached via phone at 781-301-6700 and via email at [email protected]. Learn More on Andrew L. Ross' contact information.
Has Andrew L. Ross been buying or selling shares of iSpecimen?: Andrew L. Ross has not been actively trading shares of iSpecimen over the course of the past ninety days. Most recently, on Monday, November 15th, Andrew L. Ross bought 1,000 shares of iSpecimen stock. The stock was acquired at an average cost of $5.29 per share, with a total value of $5,290.00. Learn More on Andrew L. Ross' trading history.
Who are iSpecimen's active insiders?: iSpecimen's insider roster includes Tracy Curley (CFO), and Andrew Ross (Director). Learn More on iSpecimen's active insiders.
Are insiders buying or selling shares of iSpecimen?: During the last year, iSpecimen insiders bought shares 2 times. They purchased a total of 22,400 shares worth more than $18,460.00. The most recent insider tranaction occured on September, 14th when insider Benjamin Bielak bought 18,000 shares worth more than $12,960.00. Insiders at iSpecimen own 32.7% of the company. Learn More about insider trades at iSpecimen.
Information on this page was last updated on 9/14/2023.

Andrew L. Ross Insider Trading History at iSpecimen

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
11/15/2021	Buy	1,000	$5.29	$5,290.00
11/10/2021	Buy	500	$5.85	$2,925.00
11/8/2021	Buy	1,000	$5.73	$5,730.00
6/23/2021	Buy	400	$6.52	$2,608.00
6/17/2021	Buy	100	$6.27	$627.00

Andrew L. Ross Buying and Selling Activity at iSpecimen

iSpecimen Company Overview

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Today's Range

Now: $0.21

$0.21

$0.23

50 Day Range

MA: $0.36

$0.21

$0.48

2 Week Range

Now: $0.21

$0.20

$2.05

Volume

98,954 shs

Average Volume

145,291 shs

Market Capitalization

$1.98 million

P/E Ratio

N/A

Dividend Yield